Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Columbia University researchers found "a significant reduction in opioid positivity for drivers aged 21 to 40 years" in states with operational medical marijuana laws. (Photo: Dank Depot/cc/flickr)

Confirming Big Pharma Fears, Study Suggests Medical Marijuana Laws Decrease Opioid Use

Study comes after reporting revealed fentanyl-maker pouring money into Arizona's anti-legalization effort

Lauren McCauley

It is of little wonder that Big Pharma has been exposed actively undermining efforts to legalize marijuana, after new research on Thursday found a drop in the use of opioid painkillers in that states that allow people to treat pain with good, ol' Mary Jane.

The study, published in the American Journal of Public Health, examined data on traffic fatalities in 18 states and analyzed the cases in which the presence of opioids was detected. In states that had operational medical marijuana laws, which included either "allowances for home cultivation or active dispensaries," the Columbia University researchers found "a significant reduction in opioid positivity for drivers aged 21 to 40 years."

Thus, the researchers concluded that such laws "may reduce opioid use and overdose."

"We would expect the adverse consequences of opioid use to decrease over time in states where medical marijuana use is legal, as individuals substitute marijuana for opioids in the treatment of severe or chronic pain," explained lead author June H. Kim, a doctoral student in the Department of Epidemiology at Columbia's Mailman School of Public Health.

While not the first study to suggest that legalizing marijuana may be a solution to combat the national opioid abuse crisis, the report comes after it was revealed that in Arizona the company behind the fentanyl-based medication Subsys has been pouring money into an anti-legalization campaign in an apparent bid to "eliminate the competition."

The pharmaceutical company is currently facing multiple investigations for encouraging doctors to prescribe Subsys, a fast-acting and highly-addictive drug intended to alleviate cancer pain, for off-label uses. The manufacturer, Insys, is also currently developing a synthetic version of tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, to treat cancer-related nausea and vomiting.

"It's not the first time pharmaceutical companies have helped bankroll the opposition to marijuana reform," noted journalist Lee Fang. "The Community Anti-Drug Coalition of America, a nonprofit that organizes anti-marijuana activism across the country, has long received corporate sponsorship from Purdue Pharma, the makers of Oxycontin, and Janssen Pharmaceuticals, another opioid manufacturer."

Fang also revealed this week that major alcohol industry groups, also seemingly concerned about the competition, have made significant contributions to anti-pot legalization efforts in Massachusetts and Arizona.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Senate Dems Help Torpedo Resolution That Would Have Blocked $650 Million Arms Sale to Saudi Arabia

"My simple question is, why in the world would the United States reward a regime that has caused such pain in Yemen with more weapons," Sanders asked after the vote. "The answer is we should not."

Brett Wilkins ·


Amnesty Scorecard Finds Twitter Failing to Protect Women From Online Abuse

"As our world has become increasingly dependent on digital spaces during the Covid-19 pandemic, it's critical that Twitter meet this moment with demonstrated commitment to improving the online experiences of all users, regardless of their identity."

Jessica Corbett ·


Filibuster Reform for Debt Ceiling Fight But Not Voting Rights or Reproductive Freedom?

"If our senators are willing to suspend the filibuster to protect our economy, they should be willing to suspend it to protect our democracy and our freedom to vote."

Jessica Corbett ·


As Senate Holds Guantánamo Hearing, Biden Urged to 'Finally End This Chapter of Injustice'

"Guantánamo is a centerpiece of the forever wars. It is a shameful symbol of racial injustice, torture, and violations of the Constitution and international law."

Brett Wilkins ·


'Unbreakable Solidarity': Kellogg's Workers Reject Contract That Would Leave New Employees Out of Benefits

"We're not willing to sell our souls for our future employees that are going to work side by side with us but not get the same pay or benefits."

Julia Conley ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo